These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 30715101)
1. Tissue Transglutaminase-Mediated AT1 Receptor Sensitization Underlies Pro-inflammatory Cytokine LIGHT-Induced Hypertension. Liu C; Luo R; Wang W; Peng Z; Johnson GVW; Kellems RE; Xia Y Am J Hypertens; 2019 Apr; 32(5):476-485. PubMed ID: 30715101 [TBL] [Abstract][Full Text] [Related]
2. Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase. Liu C; Kellems RE; Xia Y Am J Hypertens; 2017 Aug; 30(8):756-764. PubMed ID: 28338973 [TBL] [Abstract][Full Text] [Related]
3. Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification. Liu C; Wang W; Parchim N; Irani RA; Blackwell SC; Sibai B; Jin J; Kellems RE; Xia Y Hypertension; 2014 Feb; 63(2):353-61. PubMed ID: 24191290 [TBL] [Abstract][Full Text] [Related]
4. Transglutaminase is a Critical Link Between Inflammation and Hypertension. Luo R; Liu C; Elliott SE; Wang W; Parchim N; Iriyama T; Daugherty PS; Tao L; Eltzschig HK; Blackwell SC; Sibai BM; Kellems RE; Xia Y J Am Heart Assoc; 2016 Jun; 5(7):. PubMed ID: 27364991 [TBL] [Abstract][Full Text] [Related]
7. Central Renin-Angiotensin System Activation and Inflammation Induced by High-Fat Diet Sensitize Angiotensin II-Elicited Hypertension. Xue B; Thunhorst RL; Yu Y; Guo F; Beltz TG; Felder RB; Johnson AK Hypertension; 2016 Jan; 67(1):163-70. PubMed ID: 26573717 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. Deshotels MR; Xia H; Sriramula S; Lazartigues E; Filipeanu CM Hypertension; 2014 Dec; 64(6):1368-1375. PubMed ID: 25225202 [TBL] [Abstract][Full Text] [Related]
9. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR. Castro-Moreno P; Pardo JP; Hernández-Muñoz R; López-Guerrero JJ; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M; Villalobos-Molina R Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):61-9. PubMed ID: 22994939 [TBL] [Abstract][Full Text] [Related]
10. Interaction of Angiotensin II AT1 Receptors with Purinergic P2X Receptors in Regulating Renal Afferent Arterioles in Angiotensin II-Dependent Hypertension. Kulthinee S; Tasanarong A; Franco M; Navar LG Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511174 [TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 prevents sustained angiotensin II-induced resistance artery constriction and obesity-induced high blood pressure. Czikora I; Feher A; Lucas R; Fulton DJ; Bagi Z Am J Physiol Heart Circ Physiol; 2015 Mar; 308(5):H376-85. PubMed ID: 25527780 [TBL] [Abstract][Full Text] [Related]
12. Purinergic P2X Kulthinee S; Shao W; Franco M; Navar LG Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1400-F1408. PubMed ID: 32308022 [TBL] [Abstract][Full Text] [Related]
13. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension. Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis. Chrobok NL; Bol JGJM; Jongenelen CA; Brevé JJP; El Alaoui S; Wilhelmus MMM; Drukarch B; van Dam AM PLoS One; 2018; 13(4):e0196433. PubMed ID: 29689097 [TBL] [Abstract][Full Text] [Related]
16. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling. Banday AA; Lokhandwala MF Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661 [TBL] [Abstract][Full Text] [Related]
17. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats. Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061 [TBL] [Abstract][Full Text] [Related]
18. Soluble (pro)renin receptor induces endothelial dysfunction and hypertension in mice with diet-induced obesity via activation of angiotensin II type 1 receptor. Fu Z; Wang F; Liu X; Hu J; Su J; Lu X; Lu A; Cho JM; Symons JD; Zou CJ; Yang T Clin Sci (Lond); 2021 Mar; 135(6):793-810. PubMed ID: 33625485 [TBL] [Abstract][Full Text] [Related]
19. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]